Hakai acts as a coregulator of estrogen receptor alpha in breast cancer cells

Cancer Science

Volumn 101, Issue 9, 2010, Pages 2019-2025

  Gong, Eun Yeung ^a   Park, Eunsook ^a   Lee, Keesook ^a  

^a Chonnam National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; ESTROGEN RECEPTOR ALPHA; NUCLEAR RECEPTOR COACTIVATOR 2; PROTEIN HAKAI; STEROID RECEPTOR COACTIVATOR 1; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BREAST CANCER; CANCER CELL; CANCER GROWTH; CELL MIGRATION; CELL PROLIFERATION; DNA BINDING; ENZYME ACTIVITY; NONHUMAN; PRIORITY JOURNAL; TRANSACTIVATION; TRANSCRIPTION REGULATION;

ANIMALS; BINDING, COMPETITIVE; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CERCOPITHECUS AETHIOPS; COS CELLS; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; FEMALE; HUMANS; IMMUNOPRECIPITATION; NUCLEAR RECEPTOR COACTIVATOR 2; NUCLEAR RECEPTOR COACTIVATOR 3; NUCLEAR RECEPTOR COACTIVATORS; PROTEIN BINDING; TESTOSTERONE; TRANSCRIPTIONAL ACTIVATION; TRANSFECTION; TWO-HYBRID SYSTEM TECHNIQUES; UBIQUITIN-PROTEIN LIGASES;

EID: 77955950691     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2010.01636.x     Document Type: Article

References (35)

1. Bocchinfuso WP, Hively WP, Couse JF, Varmus HE, Korach KS. A mouse mammary tumor virus-wnt-1 transgene induces mammary gland hyperplasia and tumorigenesis in mice lacking estrogen receptor-α. Cancer Res 1999, 59:1869-76.
2. Deroo BJ, Korach KS. Estrogen receptor and human disease. J Clin Invest 2006, 116:561-70.
3. Giretti MS, Fu XD, De Rosa G. Extra-nuclear signalling of estrogen receptor to breast cancer cytoskeletal remodeling, migration and invasion. PLoS ONE 2008, 3:e2238.
4. Robyr D, Wolffe AP, Wahi W. Nuclear hormone receptor coregulators in action: diversity for shared tasks. Mol Endocrinol 2000, 14:329-47.
5. Yao TP, Ku G, Zhou N, Scully R, Livingston DM. The nuclear hormone receptor coactivator SRC-1 is a specific target of p300. Proc Natl Acad Sci USA 1996, 93:10626-31.
6. Chakravarti D, LaMorte VJ, Nelson MC. Role of CBP/p300 in nuclear receptor signaling. Nature 1996, 383:99-103.
7. Endoh H, Maruyama K, Masuhiro Y. Purification and identification of p68 RNA helicase acting as a transcriptional coactivator specific for the activation function 1 of human estrogen receptor alpha. Mol Cell Biol 1999, 19:5363-72.
8. Alen P, Claessens F, Schoenmakers E. Interaction of the putative androgen receptor-specific coactivator ARA70/ELE1alpha with multiple steroid receptors and identification of an internally deleted ELE1beta isoform. Mol Endocrinol 1999, 13:117-28.
9. Neuman E, Ladha MH, Lin M. Cyclin D1 stimulation of estrogen receptor transcriptional activity independent of cdk4. Mol Cell Biol 1997, 17:5338-47.
10. Ling L, Yan J, Zhu J. Ligand-independent activation of estrogen receptor α by XBP-1. Nucleic Acids Res 2003, 31:5266-74.
11. Lavinsky RM, Jepsen K, Heinzel T. Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes. Proc Natl Acad Sci USA 1998, 95:2920-5.
12. Smith CL, Nawaz Z, O'Malley BW. Coactivator and corepressor regulation of the agonist/antagonist activity of the mixed antiestrogen, 4-hydroxy-tamoxifen. Mol Endocrinol 1997, 11:657-66.
13. Johansson L, Thomsen JS, Damdimopoulos AE, Spyrou G, Gustafsson JA, Treuter E. The orphan nuclear receptor SHP inhibits agonist-dependent transcriptional activity of estrogen receptor alpha and beta. J Biol Chem 1999, 274:345-53.
14. Zhao HH, Herrera RE, Coronado-Heinsohn E. Forkhead homologue in rhabdomyosarcoma functions as a bifunctional nuclear receptor-interacting protein with both coactivator and corepressor functions. J Biol Chem 2001, 276:27907-12.
15. Hu YC, Shyr CR, Che W, Mu XM, Kim E, Chang C. Suppression of estrogen receptor-mediated transcription and cell growth by interaction with TR2 orphan receptor. J Biol Chem 2002, 277:33571-9.
16. Fan S, Ma YX, Wang C. Role of direct interaction in BRCA1 inhibition of estrogen receptor activity. Oncogene 2001, 20:77-87.
17. Zheng L, Annab LA, Afshari CA, Lee WH, Boyer T. BRCA1 mediateds ligand-independent transcriptional repression of the estrogen receptor. Proc Natl Acad Sci USA 2001, 98:9587-92.
18. Fujita Y, Krause G, Scheffner M. Hakai, a c-Cbl-like protein, ubiquitinates and induces endocytosis of the E-cadherin complex. Nat Cell Biol 2002, 4:222-31.
19. Figueroa A, Kotani H, Toda Y. Novel roles of Hakai in cell proliferation and oncogenesis. Mol Biol Cell 2009, 20:3533-42.
20. Hong CY, Suh JH, Kim K. Modulation of androgen receptor transactivation by the SWI3-related gene product (SRG3) in multiple ways. Mol Cell Biol 2005, 25:4841-52.
21. Seo JH, Gong EY, Kim JB, Lee IK, Choi HS, Lee K. Sterol regulatory element-binding protein-1c represses the transactivation of androgen receptor and androgen-dependent growth of prostatic cells. Mol Cancer Res 2008, 6:314-24.
22. Chattopadhyay S, Gong EY, Hwang M. The CCAAT enhancer-binding protein-a negatively regulates the transactivation of androgen receptor in prostate cancer cells. Mol Endocrinol 2006, 20:984-95.
23. Lee HJ, Chattopadhyay S, Gong EY, Ahn RS, Lee K. Antiandrogenic effects of bisphenol A and nonylphenol on the function of androgen receptor. Toxicol Sci 2003, 75:40-6.
24. Jeong BC, Hong CY, Chattopadhyay S. Androgen receptor corepressor-19 kDa (ARR19), a leucine-rich protein that represses the transcriptional activity of androgen receptor through recruitment of histone deacetylase. Mol Endocrinol 2004, 18:13-25.
25. Lee SY, Gong EY, Hong CY. ROS inhibit the expression of testicular steroidogenic enzyme genes via the suppression of Nur77 transactivation. Free Radic Biol Med 2009, 47:1591-600.
26. Solera J, Espinosa A, Geijo P. Treatment of human brucellosis with netilmicin and doxycycline. Clin Infect Dis 1996, 22:441-5.
27. Shang Y, Brown M. Molecular determinants for the tissue specificity of SERMs. Science 2002, 295:2465-8.
28. Colley SM, Iyer KR, Leedman PJ. The RNA coregulator SRA, its binding proteins and nuclear receptor signaling activity. IUBMB Life 2008, 60:159-64.
29. Zhang H, Thomsen JS, Johansson L, Gustafsson JA, Treuter E. DAX-1 functions as an LXXLL-containing corepressor for activated estrogen receptors. J Biol Chem 2000, 275:39855-9.
30. Yu X, Wu LC, Bowcock AM, Aronheim A, Baer R. The C-terminal (BRCT) domains of BRCA1 interact in vivo with CtIP, a protein implicated in the CtBP pathway of transcriotional repression. J Biol Chem 1998, 25:25388-92.
31. Xian Ma Y, Tomita Y, Fan S. Structural determinants of the BRCA1: estrogen receptor interaction. Oncogene 2005, 24:1831-46.
32. Johnsen SA, Gungor C, Prenzel T. Regulation of estrogen-dependent transcription by LIM cofactors CLIM and RLIM in breast cancer. Cancer Res 2009, 69:128-36.
33. Zilfou JT, Hoffman WH, Sank M, Geprge DL, Murphy M. The corepressor mSin3a interacts with the proline-rich domain of p53 and protects p53 from proteasome-mediated degradation. Mol Cell Biol 2001, 21:3974-85.
34. Chen G, Courey AJ. Groucho/TLE family proteins and transcriptional repression. Gene 2000, 249:1-16.
35. Ilyemere VP, Davies NH, Brownlee GG. The activation function 2 domain of hepatic nuclear factor 4 is regulated by a short C-terminal proline-rich repressor domain. Nucleic Acids Res 1998, 26:2098-104.